Announced Wed, 8 Jul · 10:59 IST
Dematerialisation compliance certificate submitted for June 2026 quarter
Compliance View source PDF
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹831.00
prior close
₹831.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.2+0.4+0.3-1.8+0.8-0.1-1.0+2.6-0.7————
Up moveDown movePending
AI summary
Alembic Pharmaceuticals submitted the Regulation 74-5 compliance certificate for the quarter ended 30 June 2026. The certificate, issued by registrar MUFG Intime India (formerly Link Intime), confirms that shares received for dematerialisation during the quarter were processed and confirmed to the depositories within SEBI timelines. This is a routine quarterly compliance filing required for all listed companies.
Likely market impact
Routine SEBI compliance filing; no material impact on operations or shareholders.